Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06246916
Title A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCHealth RECRUITING Fort Collins Colorado 80528 United States Details
Boca Raton Clinical Research (BRCR) Global RECRUITING Plantation Florida 33322 United States Details
Illinois CancerCare RECRUITING Peoria Illinois 61615 United States Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Oncology Hematology West, P.C. dba Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68130 United States Details
Comprehensive Cancer Centers of Nevada - Southwest RECRUITING Las Vegas Nevada 89148 United States Details
New York Oncology Hematology RECRUITING Albany New York 12206 United States Details
University of Tennessee Medical Center RECRUITING Knoxville Tennessee 37920 United States Details
University of Wisconsin Carbone Cancer Center RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field